Akoya

Q1 2023 revenue $21.4 million, 27% y/y growth Reiterating FY 2023…

Joe Driscoll to Retire After More than Four Successful Years as…

MARLBOROUGH, Mass., Jan. 08, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced preliminary unaudited revenue for the fourth quarter and full year ended December 31,…

BOSTON--(BUSINESS WIRE)--Akoya announced today that Paul LaRusso has been named Chief Executive Officer and will remain a member of Akoya’s board of directors, succeeding Stuart Rubinstein in the role who, in early 2022 shared his desire to…

MARLBOROUGH, Mass., Dec. 28, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will be participating in the 41st Annual J.P. Morgan Healthcare Conference.…